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Introduction
A predictor of a poor prognosis, worsening of renal function (WRF) often manifests in patients with heart failure (HF). Worsening of renal function is associated with an increased mortality in these patients, [1] as well as increased in-hospital costs, in-hospital mortality, length of stay, and likelihood of readmission [2] . According to data from large registries, 30% of patients hospitalized for acutely decompensated heart failure (ADHF) exhibit moderate to severe WRF. If patients with mild WRF are included, the percentage climbs over 50% [3] . Worsening of renal function is also closely linked with deterioration in renal function over time, after an initial hospitalization, which leads to the development of renal failure, respectively.
In patients with acute HF hemodynamic balance, maintained by kidneys, is often disrupted, resulting in decreased organ perfusion and ultimately organ failure and possibly death. Heart failure with reduced left ventricle ejection fraction (HFrEF) is characterized by impaired left ventricular systolic function and poor cardiac output with activation of compensatory mechanisms such as the renin-angiotensin-aldosterone system, the sympathetic nervous system, and other mediators, which interact to maintain the fluid volume [4] . Furthermore, decreased renal perfusion in addition to nephrotoxic agents, eventually leads to kidney injury in those patients [5] . Heart failure with preserved left ventricle ejection fraction (HFpEF), mostly in patients with thick ventricular walls, and a small ventricular cavity, is also characterized by a low cardiac output in acute deterioration of HF. The high end-diastolic pressure is transferred back to the pulmonary capillaries, the stress of which results in dyspnoea upon exertion, and these pathophysiological abnormalities trigger neurohormonal activation, as happens in HFrEF [6] . The identification of risk factors associated with worsening of renal function in patients with HD may provide an opportunity to reduce the risk of complications and improve the outcome in this setting.
Therefore the aim of the parent study was to determine risk factors associated with worsening of renal function in patients hospitalized for acutely decompensated heart failure
Patients and methods
We observed 330 patients with ADHF, of both sexes, hospitalized at the Clinic for cardiovascular diseases, Clinical Centre Nis, Serbia, between March and November 2014.
The study was designed as a cross-sectional, retrospective study, was approved by the Ethic Committee of Clinical Center Nis, and conducted in compliance with the Declaration of Helsinki and Good Clinical Practice Guidelines.
The diagnosis of HF was established according to the guidelines of the European Society of Cardiology (ESC) [7] . All patients with left ventricular ejection fraction (LVEF)≤45% -heart failure with reduced left ventricle ejection fraction (HFrEF), or with heart failure with preserved left ventricle ejection fraction (HFpEF), having New York Heart Association function (NYHA) class II to IV, [8] were enrolled in the study.
Echocardiography was performed on VIVID 4GE ultrasound system and LVEF was measured according to Simpson biplane method. These measurements were performed as soon as the patients were able to have compliance during the examination.
The reasons for hospitalization were hypertensive crisis 25 (7.5%), chronic ischemic cardiomyopathy, without increased specific markers of myocardial necrosis 58 (17.5%), valvular heart disease 69 (21%), and dilated cardiomyopathy 178 (53.9%), as underlying conditions for the development of ADHF, data shown in Table 1 . Acute heart failure had 95 (28.7%) of patients, and acute decompensation of a preexisting heart disease had 235 (71.3%). Patients who had previous diagnosis of diabetes mellitus (type 1 and 2), chronic renal failure grade 4 and 5, malignant diseases, and chronic inflammatory diseases were deferred from the study. The patients with acute coronary syndrome, coronarography or percutaneous coronary intervention during hospitalization and 30 days before were also excluded.
All patients hospitalized with the heart failure (HF) were divided into the two groups, according to the presence of worsening of renal function, 7 days after admittance. We assessed kidney function by measuring serum creatinine concentration. An increase in serum creatinine by at least 25% or more compared to the baseline values, was defined as worsening of renal function [9] . Using the simplified Modification of Diet in Renal Disease (MDRD) formula, a suggested method for assessment in patients with HF, we also estimated glomerular filtration rate (eGFR) [10] . According to this method, we determined stages of chronic kidney disease at admittance and after 7 days of hospitalization. 
Statistical Analyses
Characteristics of the study group were expressed as mean±SD (continuous variables) with number and % in brackets (categorical variables). We compared data of patients using Student t-test for normally distributed data (expressed as mean±SD) and Mann-Whitney U test for non-parametric variables. Univariate logistic regression was used to calculate Odds Ratio (OR) and 95% Confidence Intervals (CI) for occurrence of WRF.
The relationship between selected variables was determined by Pearson's correlation coefficient I. All analyses were performed with SPSS version 16.0 (SPSS, Chicago, IL, United States) at the significance level set at p<0.05.
Results
Worsening of renal function was determined in 215 (65.2%) patients hospitalized with heart failure after seven days of hospitalization. Significant differences were found between patients who developed WRF and the control group. Heart failure patients who developed WRF were older, more hypertensive and less likely to be with the first episodes of acute heart failure and preserved ejection fraction. They had similar lipid profile except higher triglycerides (p<0.01), higher fasting glycemia (p<0.05), serum urea and creatinine concentration (p<0.01). Patients in the clinical group had lower serum potassium (p<0.01), sodium concentration, (p<0.01), lower values of systolic (p<0.01), and diastolic blood pressure (p<0.01), and eGFR (p<0.01) at admittance, compared to the control group. There were no significant differences according to patients' gender, LDL and HDL cholesterol concentration. All data presented in Table 2 .
The analysis of the stages of chronic kidney disease showed significant differences in distribution among subgroups of HF patients. The patients in the clinical group had severely impaired kidney function compared to the control group at admittance (p<0.01), Table 2 . Moreover, the development of chronic kidney disease grade 3 was registered in 102 (47.4%) in WRF group after 7 days of hospitalization (data not shown).
The parameters of global renal function (plasma concentration of urea, creatinine and eGFR) and LVEF according to the age, gender and type of HF (HFrEF or HFpEF) in the subgroup of patients with WRF are shown in Table 3 . We found that urea and creatinine concentration were significantly higher and eGFR and LVEF lower in patients older than 65 years. The female patients also had significantly higher urea and lower eGFR compared to the males. The patients with HFrEF had significantly higher creatinine concentration and lower eGFR, thus presenting older female patients with reduced EF as particularly predisposed to the WRF.
Non-adjusted Odds Ratios (OR) for renal dysfunction were presented in Table 4 .
Non-adjusted OR showed that there was a significant risk for development of WRF during hospitalization in patients older than 65 years (OR=4.3; 95%CI 3.8-6.0), history of smoking (OR=3.9; 95%CI 2.5-5.7), total plasma cholesterol (>5.2 mmol/L) (OR=1.6; (age over 65, smoking, hypertension and hyponatriemia) increased the probability for worsening of renal function more than two times.
Discussion
Heart failure is a leading cause of hospitalization in the age group of 65 years and older, represents a significant economic burden [5] , and eventually leads to kidney injury.
The present study adds to the current data that worsening of renal function is an expecting finding among older patients hospitalized for HF. Worsening of renal functions frequency ranges from 35 to 70% in various studies [12] , and have a high in-hospital mortality [13] .
In a meta-analysis unadjusted mortality rate at one year follow-up was 51% in those with moderate to severe renal impairment, compared to 26% in those without any renal impairment [14] . The prevalence of WRF, as well as the development of kidney failure stages III, (determined as eGFR<60/ml/min/m 2 ), in our patients hospitalized with ADHF was 65.2%, and 47.4% prospectively, which is in accordance with current data. Some researchers found "moderate" renal failure (creatinine clearance<60/ml/min/m 2 ) in 22.5%
of their heart failure patients [15] , while in the Valsartan in Heart Failure (Val-HeFT) trial [16] (n=5010), eGFR was found to be below 60ml/min/m 2 in 58% of patients. In both studies, however, decreased eGFR was a predictor of a poor prognosis.
Baseline renal insufficiency was reported to increase the number of hospitalizations due to worsening of HF, and these individuals have high likelihood of cardiovascular death [12] . Possible mechanism for development of renal dysfunction is arterial hypotension followed by severe and prolonged kidney hypoperfusion. In 10.2% of our patients with HF, prompt decrease in kidney function at hospital admission was noticed. Age and baseline renal function were determined as risk factors for worsening of renal function and acutisation in chronic HF patients [17] .
Several studies showed that the prevalence of kidney failure rises with age [15] [16] [17] [18] .
In accordance, in our study, significantly more patients older than 65 years had worsening of renal function, and this was an independent risk factor for its occurrence, (OR 4.3).
Traditional risk factors for heart disease, such as hypertension, smoking and total cholesterol (>5.20 mmol/L), also showed significance for WRF, although with a slightly smaller predictive values.
Worsening of renal function in our study was equally distributed between gender, despite the fact that cardiovascular diseases are more frequent in males compared to females. This could be explained by physiological changes after menopause, most probably due to the loss of protective estrogen effect on vasculature and great proportion of patients aged over 65 years. Estrogen decreases expression of angiotensin type 1 receptor and angiotensin-converting enzyme, and causes the release of angiotensinogen substrate [19] .
In our study, HFrEF (≤45% LVEF) was found to be a significant risk factor for WRF with moderately higher risk (OR 1.3), unlike HFpEF. However, in other studies various relations between heart and kidney function parameters were determined.
Apparently, elevation in both ventricles' end-diastolic pressures and venous pressure contribute to renal dysfunction by impairing forward blood flow and by increasing renal venous pressure [20] . Predomination of a single process is probably influenced by the stage of heart disease and neurohormonal status of a patient. Acute renal injury, as a complication in congestive HF patients treated with diuretics, was observed more often in those with HFrEF (40%) than with HFpEF (28%) [17] . Additionally, WRF is certainly favored by pronounced vasoconstriction and sodium retention in acutely decompensated HF patients [21] . Worsening of renal function during the first 3 days of hospitalization was also reported in 47% of patients with acutely decompensated HF [22] . Heart failure with reduced left ventricle ejection fraction as the significant risk factor for kidney injury in our HF patients was likely due to its prolonged hypoperfusion effect on kidneys.
Urea, creatinine and eGFR were higher in our patients with WRF that were older than 65 years compared to younger. As a consequence of HF related increase in venous pressure in kidneys, pressures in interstitial space and Bowman's capsule also increase, and lead to greater urea reabsorption. Beside, in low-output HF, arterial perfusion is maintained by release of neurohumoral mediators, among which is arginine vasopressin that mediates urea reabsorption [12, 20] . However, urea may not be reliable index of WRF, mostly compared to eGFR, because its serum concentrations are affected by different elements of metabolism [12] . This is perhaps the reason of insignificant correlation between LVEF and urea, nor creatinine values in our study. Prolonged hyponatremia has been proven as an independent cardiovascular risk factor, and also an independent factor of mortality in this group of patients, mostly due to the long-term diuretic therapy.
We suppose that higher urea concentrations in our female patients are due to lower percent of total body water and significantly faster decline of eGFR with age, compared to the males [23] .
Conclusion
Worsening of renal function is common in patients hospitalized with ADHF. We have demonstrated that age over 65 years, heart failure with reduced left ventricle ejection fraction, smoking, hyponatremia, elevated total cholesterol and hypertension, were significant risk factors for worsening of renal function. Our results indicate that age over 65 could be the best prognostic tool, among evaluated, for identification for worsening of renal function in patients with heart damage. The other assessed parameters, heart failure with preserved left ventricle ejection fraction, elevated triglycerides level, hypokalemia, and gender did not have any significance for worsening of renal function in patients hospitalized with heart failure.
The results of our study may provide to the clinician's very important knowledge about the elderly patients, who are under a greater risk for renal damage and therefore possible prevention of irreversible changes.
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